Yat Sun Or, Chief Scientific Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 5,000 shares at $39.48 ($197K) on 2014-08-13, disclosed to the SEC on 2014-08-15.
Scheduled sale ($197k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.48 | 4,900 | $193K | 98.0% |
| 2 | $40.04 | 100 | $4K | 2.0% |
| Total | $39.49 avg | 5,000 | $197K | 100% |
| Filing → |
| ENTA | SELL | 2023-12-06 | $23K | — | Filing → |
| ENTA | SELL | 2023-03-17 | $1.2M | — | Filing → |
| ENTA | SELL | 2019-03-04 | $2.1M | — | Filing → |